Upcoming Webinars
-
mRNA Patent Wars Update: Litigations Expand and Key Rulings Expected in 2025
Join Rothwell Figg Partner Dan Shores as he gives a mRNA patent wars update.
Register for mRNA Patent Wars Update: Litigations Expand and Key Rulings Expected in 2025 Read More about mRNA Patent Wars Update: Litigations Expand and Key Rulings Expected in 2025 -
Medical Device v2.0: Safer but Riskier?
Join Clark Hill PLC Member Matt Marshall as he discusses the requirements of GMP relating to product improvement, the potential risks of such improvements in litigation, and how such improvements may run afoul of a device’s existing FDA clearance.
Register for Medical Device v2.0: Safer but Riskier? Read More about Medical Device v2.0: Safer but Riskier?
Past Webinars
-
Navigating Risks for Foreign Manufacturers Whose Products are Distributed in the U.S.
Join Wilson Elser Partners Kathleen Warin and Daniel Tranen as they explore the complexities of product liability and litigation risks for products sold in the U.S. while originating elsewhere.
Read More about Navigating Risks for Foreign Manufacturers Whose Products are Distributed in the U.S. -
Claims 2024: What’s Happening and What You Need to Know
Join Sonia Valdes (VP, Claims), Andrew Hall (Executive Claims Specialist), and Lauren Hulbert (Senior Claims Examiner) for a recap of what’s happening in the life science claims and litigation world.
Read More about Claims 2024: What’s Happening and What You Need to Know -
Ripped from the Headlines: Hot Topics in Life Sciences 2024
The life sciences industry is constantly changing, and equally dynamic are the challenges industry participants encounter. Join Medmarc's Risk Managers to discuss these changes from 2024.
Read More about Ripped from the Headlines: Hot Topics in Life Sciences 2024 -
FDA Regulation of AI in Life Sciences Webinar | Medmarc
Join us to learn about strategies for approaching FDA with your AI products. Nathan Downing of Gardner Law will discuss pre-market activities, submission strategies, and post-market considerations to make your regulatory strategy a success.
Read More about FDA Regulation of AI